BLU-554(1707289-21-1)名称与标识符
名称
中文别名：
BLU-554;N-((3S,4S)-3-((6-(2,6-二氯-3,5-二甲氧基苯基)喹唑啉-2-基)氨基)四氢-2H-吡喃-4-基)丙烯酰胺;
英文别名：
BLU-554;BLU 554;Fisogatinib;BLU554;N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide;Fisogatinib [INN];fisogatinib (proposed INN);5Q7R99CKV2;BLU 554 [WHO-DD];GTPL10220;MGZKYOAQVGSSGC-DLBZAZTESA-N;N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide;CS3008;s8503;N-[(3S,;N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino]tetrahydro-2H-pyran-4-yl]-2-propenamide;NSC795718;AS-55934;X-439161;SCHEMBL16668287;CCG-269714;BDBM50575072;BLU111362;CS-5986;BLU554(Fisogatinib)?;X439161;DA-71570;N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]oxan-4-yl]prop-2-enamide;FISOGATINIB [WHO-DD];WHO 10947;D11737;C24H24Cl2N4O4;CHEMBL4514636;N-[(3S,4S)-3-{[6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino}oxan-4-yl]prop-2-enamide;HY-100492;Fisogatinib [USAN];Fisogatinib (USAN/INN);MFCD30496704;EX-A841;BB160379;2-Propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-;UNII-5Q7R99CKV2;Q29209801;GLXC-10936;1707289-21-1;Fisogatinib [USAN:INN];NSC-795718;BLU-111362;BLU554(Fisogatinib);AC-29871;AKOS030632994;
标识符
InChIKey：
MGZKYOAQVGSSGC-DLBZAZTESA-N
Inchi：
1S/C24H24Cl2N4O4/c1-4-20(31)28-16-7-8-34-12-17(16)30-24-27-11-14-9-13(5-6-15(14)29-24)21-22(25)18(32-2)10-19(33-3)23(21)26/h4-6,9-11,16-17H,1,7-8,12H2,2-3H3,(H,28,31)(H,27,29,30)/t16-,17+/m0/s1
SMILES：
ClC1C(=C([H])C(=C(C=1C1C([H])=C([H])C2C(C=1[H])=C([H])N=C(N=2)N([H])[C@]1([H])C([H])([H])OC([H])([H])C([H])([H])[C@]1([H])N([H])C(C([H])=C([H])[H])=O)Cl)OC([H])([H])[H])OC([H])([H])[H]
2881489226 
